United States· US:84755-0010_4e6af886-2e2f-0343-e063-6394a90ad095
KRX Aesthetics PD-13 Therapy
A methyl aminolevulinate product containing methyl aminolevulinate hydrochloride, registered in United States by KRX RESOURCES SDN. BHD.. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Methyl aminolevulinate is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XD03 (methyl aminolevulinate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Methyl aminolevulinate · ATC L01XD03
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHYL AMINOLEVULINATE HYDROCHLORIDE
- Manufacturer
- KRX RESOURCES SDN. BHD.
- Country
- United States (US)
- ATC code
- L01XD03
- ATC class
- Methyl aminolevulinate
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11847550010115 mL in 1 PACKAGE (84755-0010-1)
- ndc1184755-0010-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methyl aminolevulinate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandLuxeraGalderma Nordic AB
- SwedenLuxera 160 mg/g KrämGalderma Nordic AB
- GermanyLuxermGalderma Laboratorium Gmbh
- FranceMETVIXIA 168 mg/g, crèmeGALDERMA INTERNATIONAL
- United KingdomMetvix 16% creamGalderma (UK) Ltd
- IrelandMetvix 160 mg/g creamGalderma International
- IcelandMetvixGalderma Nordic AB*
- NorwayMetvixGalderma Nordic AB
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Luxerm, Metvix
- Belgium · Metvix
- Germany · Luxerm, Metvix
- Denmark · Metvix
- Spain · Metvix
- Finland · Metvix
- France · Metvixia
- United Kingdom (Northern Ireland) · Metvix
- Greece · Metvix
- Ireland · Metvix
- Iceland · Metvix
- Italy · Metvix
- Luxembourg · Metvix
- Malta · Metvix
- Netherlands · Metvix
- Norway · Metvix
- Portugal · Metvix
- Sweden · Luxera, Metvix
- Slovakia · Metvix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/28058ef8-3e90-4d03-8a22-672659e51053 GET /v1/drugs/28058ef8-3e90-4d03-8a22-672659e51053?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1.95",
"substance": "METHYL AMINOLEVULINATE HYDROCHLORIDE",
"productndc": "84755-0010",
"dosage_form": "SPRAY",
"dea_schedule": null,
"strength_unit": "mg/15mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about methyl aminolevulinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.